This company seems to have been delisted
Reason: Went private
Last recorded trade on: June 7, 2024
Source: https://www.fiercebiotech.com/biotech/ngm-go-private-part-135m-buyout-vc-firm-column-group
Reason: Went private
Last recorded trade on: June 7, 2024
Source: https://www.fiercebiotech.com/biotech/ngm-go-private-part-135m-buyout-vc-firm-column-group
NGM Biopharmaceuticals
NGM
1,39 €
Share price
0.00%
Change (1 day)
-55.22%
Change (1 year)
Categories
NGM Biopharmaceuticals (NGM) - Total debt
Total debt on the balance sheet as of December 2023 : N/A
According to NGM Biopharmaceuticals's latest financial reports the company's total debt is N/A. A company’s total debt is the sum of all current and non-current debts.
NGM Biopharmaceuticals - Total debt on balance sheet (from 2020 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | N/A | -100% |
| 2022-12-31 | €5.02 M | -45.66% |
| 2021-12-31 | €9.23 M | |
| 2020-12-31 | N/A |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 | N/A | N/A | 🇺🇸 USA |
 | €0.45 B | N/A | 🇺🇸 USA |